Aspen Pharma Brasil

aspenpharma.com.br

Aspen Pharma Brazil is a subsidiary of Aspen Pharmacare, the leading brand in Africa and one of the 20 largest branded generic brand in the world. Aspen Pharmacare has 18 production plants in 14 countries on six continents, and supplies medicines to more than 150 countries. The Group officially entered the Brazilian drug market in 2009 after acquiring 100% of Cellofarm, headquartered in Rio de Janeiro. Aspen do Brasil's mission is to supply the domestic market, in addition to ensuring the Group's expansion in Latin America, focusing on growth through global acquisitions with other multinationals.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CORONAVIRUS VACCINE: JOHNSON & JOHNSON PLEDGES 100M DOSES TO U.S. FOR $10 EACH

Johnson & Johnson | August 06, 2020

news image

With leading COVID-19 vaccines in late-stage testing, companies have been inking supply deals with the U.S. government for a quick rollout if their programs succeed. Now, Johnson & Johnson is getting into the act. The pharma giant struck a deal to supply 100 million doses of its candidate, Ad26.COV2.S, if the shot is cleared for use by the FDA. The U.S. government is committing just over $1 billion under the agreement for a price per dose of about $10. That compares with a lower price-...

Read More

MOVILITAS.CLOUD™ VRS SOLUTION CLARIFIES DSCSA VERIFICATION FOR PHARMACEUTICAL WHOLESALE DISTRIBUTORS AND MANUFACTURERS

Movilitas | July 13, 2020

news image

Movilitas announced today the availability of its Movilitas.Cloud™ Verification Router Service (VRS) solution that simplifies the verification process and compliance for pharmaceutical wholesale distributors and manufacturers. The new mobile app provides an out-of-the-box solution for the November 2020 Drug Supply Chain Security Act (DSCSA) saleable returns verification deadline. With the upcoming regulation, wholesale distributors must verify the serialized product identifi...

Read More

Business Insights

DIME RELEASES TOOLKITS TO IMPROVE SENSOR DATA INTEGRATION AND POWER BETTER, FASTER GLOBAL HEALTHCARE AND RESEARCH

Digital Medicine Society | July 18, 2022

news image

Today, the Digital Medicine Society released the Sensor Data Integrations Toolkits, four comprehensive toolkits to guide data producers, processors, and consumers to use the influx of data from the increased use of wearables and digital sensing products at scale. These resources are based on the Sensor Data Integrations project, comprised of healthcare leaders from Amazon Web Services Oracle, the Moffitt Cancer Center, Takeda, the US Department of Veterans Affairs and more. These toolkits will h...

Read More

Business Insights, PHARMACY MARKET

PCI PHARMA SERVICES EXPANDS BIOLOGICS LEADERSHIP WITH NEW CENTER OF EXCELLENCE FACILITY IN THE MIDWEST

PCI Pharma Services | March 20, 2023

news image

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Building on PCI’s leadership in this space with its Philadelphia Biotech Center of Excellence, the new facility is the second expansion building off the success i...

Read More
news image

CORONAVIRUS VACCINE: JOHNSON & JOHNSON PLEDGES 100M DOSES TO U.S. FOR $10 EACH

Johnson & Johnson | August 06, 2020

With leading COVID-19 vaccines in late-stage testing, companies have been inking supply deals with the U.S. government for a quick rollout if their programs succeed. Now, Johnson & Johnson is getting into the act. The pharma giant struck a deal to supply 100 million doses of its candidate, Ad26.COV2.S, if the shot is cleared for use by the FDA. The U.S. government is committing just over $1 billion under the agreement for a price per dose of about $10. That compares with a lower price-...

Read More
news image

MOVILITAS.CLOUD™ VRS SOLUTION CLARIFIES DSCSA VERIFICATION FOR PHARMACEUTICAL WHOLESALE DISTRIBUTORS AND MANUFACTURERS

Movilitas | July 13, 2020

Movilitas announced today the availability of its Movilitas.Cloud™ Verification Router Service (VRS) solution that simplifies the verification process and compliance for pharmaceutical wholesale distributors and manufacturers. The new mobile app provides an out-of-the-box solution for the November 2020 Drug Supply Chain Security Act (DSCSA) saleable returns verification deadline. With the upcoming regulation, wholesale distributors must verify the serialized product identifi...

Read More
news image

Business Insights

DIME RELEASES TOOLKITS TO IMPROVE SENSOR DATA INTEGRATION AND POWER BETTER, FASTER GLOBAL HEALTHCARE AND RESEARCH

Digital Medicine Society | July 18, 2022

Today, the Digital Medicine Society released the Sensor Data Integrations Toolkits, four comprehensive toolkits to guide data producers, processors, and consumers to use the influx of data from the increased use of wearables and digital sensing products at scale. These resources are based on the Sensor Data Integrations project, comprised of healthcare leaders from Amazon Web Services Oracle, the Moffitt Cancer Center, Takeda, the US Department of Veterans Affairs and more. These toolkits will h...

Read More
news image

Business Insights, PHARMACY MARKET

PCI PHARMA SERVICES EXPANDS BIOLOGICS LEADERSHIP WITH NEW CENTER OF EXCELLENCE FACILITY IN THE MIDWEST

PCI Pharma Services | March 20, 2023

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Building on PCI’s leadership in this space with its Philadelphia Biotech Center of Excellence, the new facility is the second expansion building off the success i...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us